Lantronix unveils the general availability of S40 Series radio nodes
Category: #tech  By Mateen Dalal  Date: 2019-09-03
  • share
  • Twitter
  • Facebook
  • LinkedIn

Lantronix unveils the general availability of S40 Series radio nodes
  • S40 Series offers temperature, light pulse counting, relative humidity and pulse counting nodes and provides users the advantages of durability with IP68-rated non-potted design.
     
  • Lantronix will present the S40 Series radio nodes in addition to some of its solutions between September 3-4 in the Asian Utility Week 2019 at MITEC, Kuala Lumpur in Malaysia.

Lantronix, a multinational company that offers secure data management and access solutions for industrial Internet of Things (IOT), reportedly announced the availability of the company’s S40 Series of low-power, shock-resistant radio nodes for environment monitoring and metering.

The S40 Series offers temperature, light pulse counting, relative humidity and pulse counting nodes and provides users the advantages of durability with an IP68-rated non-potted design. Furthermore, these nodes boast of multiple radio types along with Wireless M-Bus and LoRaWAN™ options and an ultra-long battery backup that is optimally suited for the business of optimization of energy consumption.

Lantronix VP of Strategy, Jonathan Shipman stated that the company is thrilled to provide the S40 Series nodes to IPPs, power providers and utilities. Jonathan added that the company’s solutions offer reliability and durability to any industry applications whether it is environmental monitoring, smart metering or irrigation.

Lantronix will present the S40 Series radio nodes in addition to some of its other solutions between September 3-4 in the Asian Utility Week 2019 at MITEC, Kuala Lumpur in Malaysia. Lantronix is also showcasing its entire line of Power Distribution modems which includes Automated Meter Reading, Underground and Overhead Fault Detention as well as Distribution Transformer Monitoring solutions.

The company will also showcase its Out-of-Band Management solutions, including its SLC8000, the first innovative modular console server of the industry that streamlines remote network management, power and server infrastructure at the data centers as well as remote sites.

About Lantronix:

Lantronix Inc., is a secure data management and access solutions company for the assets of Internet of Things (IoT). The company has an experience of more than two decades in the field.

 

Source credit: https://www.lantronix.com/newsroom/press-releases/lantronix-announces-general-availability-s40-series-ruggedized-low-power-radio-nodes-metering-environmental-monitoring/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Lineage Cell Therapeutics’ Renevia bags CE Mark Approval for EU market
Lineage Cell Therapeutics’ Renevia bags CE Mark Approval for EU market
By Mateen Dalal

Aesthetic medicine is increasingly being used for the treatment of physical impairments such as skin discoloration, excessive fat, scars, skin laxity, wrinkles, cellulite, and liver spots. Customer are seen demanding for resurfacing and non-invasive ...

Cipla and PULM dose first patient with Pulmazole in Phase 2 ABPA trial
Cipla and PULM dose first patient with Pulmazole in Phase 2 ABPA trial
By Mateen Dalal

There is a substantial rise in the number of people affected with pulmonary diseases like asthma. Various pharmaceutical companies in the world are combining their capabilities to find treatments for serious pulmonary diseases to address the needs of...

AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620
AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620
By Mateen Dalal

As cases of neurodegenerative diseases like Alzheimer’s and Parkinson’s are on a rise, biopharmaceutical firms are actively engaging in developing new clinical drugs. Companies are also gaining increased funding from partners to further t...